A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about:
Regulators are giving early access to medicines, but what are the downstream effects on pricing and market access?
Europe: European Commission launches the European Health Data Space (EHDS)
UK: International Health Care Outcomes Index ranks UK second lowest across major health outcomes
France: CNAM spending on medicines +11.1% in March 2022
In a ground breaking move, the international collaboration among six prominent health technology ass...
This article explores the significant disparities between the US and Europe regarding orphan drugs a...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.